"
User:VolkerMorath
From 2010.igem.org
Revision as of 21:53, 15 October 2010 by VolkerMorath (Talk | contribs)
=> Vector Plasmid
=> Capsid Coding Parts
=> Miscellaneous System parts
=> Pictures
Shielding the Viral Vector
Layers of Specificity
Employment of viral vectors for means of therapy is idea in the context of personalized medicie that gets more and more interest. In such applications the reduction of side effects and the safety of the patient in general is of the highest priority.
In order to satisfy this requirement we designed our Therapy Vector with several layers of Specificity.
The targeting of the viral vector towards the desired target cell (e.g. tumor cells) is the basic idea behind the emplyment of viral vectors for therapeutical means. There for the natural tropismn has to be knocked down and a desired tropism has to be introduced that allows differential targeting of pathological but not of off-target cells. To fulfill this mission our Virus Construction Kit offers you different solutions.
In order to satisfy this requirement we designed our Therapy Vector with several layers of Specificity.
ViralBrick compatible version of the capsid coding sequence
The insertion of sequences for functional peptides into the viral capsid is a well established and characterized possibility to retarget and modify the viral vectors. Over the last decade many different locations in the viral sequence have been evaluated for their quality to insert small peptides. We decided to use the well etablished 587 and the newly identifyed 453 integration site for our Virus Construction Kit.
For reasony of flexibility and usability we decided not to use single cutting restriction sites in stead of PCR-technology. This approach provids the advantage that all capsid coding constructs can be modifyed using ViralBricks in a single cloning step but also beared the risk to harm the functionality of the viral gene sequence. The functionality of the modified version with the introduced single cutting restriction sites was tested and the functionality was determined as comparable with the unmodifyed sequence.
In order to have these single cutting restriction sites two restriction sites had to be remooved from the Rep-protein coding region of pAAV-RepCap and the restriction sites had to be introduced into the Capsid coding region as show in the following figure.
For reasony of flexibility and usability we decided not to use single cutting restriction sites in stead of PCR-technology. This approach provids the advantage that all capsid coding constructs can be modifyed using ViralBricks in a single cloning step but also beared the risk to harm the functionality of the viral gene sequence. The functionality of the modified version with the introduced single cutting restriction sites was tested and the functionality was determined as comparable with the unmodifyed sequence.
In order to have these single cutting restriction sites two restriction sites had to be remooved from the Rep-protein coding region of pAAV-RepCap and the restriction sites had to be introduced into the Capsid coding region as show in the following figure.
